ArticleNature cancer2026

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

Elizabeth A R Garfinkle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.